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AbsTrACT
Objectives To determine the effect of heading a soccer 
ball on serum neurofilament light (NF-L) protein, plasma 
tau protein and symptom metrics including total number of 
symptoms reported and symptom severity scores on the 
Standardized Concussion Assessment Tool— 3rd edition 
(SCAT3).
Methods Eleven male collegiate soccer players were 
recruited to take part in three experimental conditions 
including heading, sham and control conditions. 
Participants were required to perform 40 headers in 20 
min in the heading condition, and control 40 soccer balls 
directed at them with their hands, chest or thigh in the 
sham condition. No ball contact was made during the 
control condition. Blood sampling and SCAT3 symptom 
assessments were completed prior to and 1 hour following 
conditions. A subset of participants returned 3 weeks 
following the heading condition for blood sampling.
results NF-L was elevated at 1 hour (p=0.004) and 1 
month (p=0.04) following the heading condition, and at 1 
hour (p=0.02) following the control condition. Tau levels 
remained unchanged following all conditions. The total 
number of symptoms (TS) and symptom severity (SS) 
scores from the SCAT3 were both elevated following the 
heading condition (p=0.01 and p=0.03, respectively). Both 
TS and SS decreased following sham (p=0.04 and p=0.04) 
and control conditions (p=0.04 and p=0.04).
Conclusion An acute bout of soccer heading is 
associated with increased NF-L concentrations at 1 
hour and 1 month following the session and can lead to 
symptoms commonly reported following sport-related 
concussion.
InTrOduCTIOn
Soccer, the most popular sport in the world 
with over 270 million active participants,1 is 
unique in that players are allowed to make 
contact with the ball using their head. The 
number of headers performed vary based on 
position and typically range from 6 to 12 per 
game with ball speeds of 80 km/h or greater.2 
There is concern surrounding the potential 
negative, long-term consequences of subcon-
cussive, repetitive head impacts sustained in 
contact sport, including headers in soccer; for 
review, see Blennow et al.3 Several retrospec-
tive cohort and case study reports describe a 
variety of neurodegenerative diseases in the 
brains of retired soccer players including 
chronic traumatic encephalopathy,4 5 amyo-
trophic lateral sclerosis6 and Alzheimer’s 
disease.7 Researchers have proposed a link 
between repetitive subconcussive head trauma 
and the development of neurodegenerative 
disease; however, with respect to heading in 
soccer, the link is not yet well established. To 
date, there is limited evidence of neuronal 
damage in active soccer players measured in 
vivo under controlled circumstances.
Decreased fractional anisotropy from diffu-
sion tensor MRI, thought to reflect white 
matter structural disruption, has been shown 
to relate to the number of headers performed 
in a year;8 however, when expanded over 
the length of a career no differences on 
MRI were seen between soccer players and 
control (ie, track and field) athletes.9 Simi-
larly, conflicting results have been found for 
blood-based biomarkers of brain trauma. In 
an observational study, serum S100B concen-
tration was shown to be elevated following 
a competitive match in elite female soccer 
players compared with pre-game levels 
and correlated with the number of headers 
performed in the game;10 however, no 
difference was found in serum S100B concen-
tration in participants who performed up 
to 20 headers when compared with control 
What are the main findings?
 ► Heading in soccer can lead to biochemical signs of 
axonal damage in serum.
 ► Repetitive subconcussive impacts in the form of 
soccer headers can lead to symptoms associated 
with sport-related concussion.
 ► Longitudinal studies should be conducted to explore 
biochemical changes in conjunction with imaging 
abnormalities.
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participants who did not participate in a heading inter-
vention.11 Several studies have shown an increase in 
serum S100B following physical exertion in the absence 
of head trauma in sports including basketball,12 cycling,13 
ice hockey,12 and running,13 which might explain why 
soccer players have higher S100B levels after a compet-
itive soccer match,14 while under controlled conditions, 
S100B levels do not change.11
To date, no fluid biomarker has shown promise at 
detecting neuronal injury as a result of repetitive head 
impacts in the form of soccer headers. Tau, a micro-
tubule-associated protein primarily found in thin, 
unmyelinated axons of the central nervous system,15 and 
neurofilament light (NF-L), highly expressed in large, 
myelinated axons,3 are promising biomarkers for the 
detection of sport-related concussion (SRC) in athletes 
with persistent symptoms.16 17 Further, serum NF-L 
is significantly elevated in patients with poor clinical 
outcome following severe traumatic brain injury18 and 
is ~10-fold higher than individuals who suffer a SRC,19 
suggesting a dose-dependent response to central nervous 
system (CNS) trauma. Plasma tau is elevated in boxers 
within 6 days of a bout compared with controls,20 and 
serum NF-L has also shown usey in detecting neuronal 
trauma from repetitive, subconcussive head impacts in 
American soccer players over the course of a season.21 
Taken together, it is clear plasma tau and serum NF-L 
are promising candidate biomarkers for CNS damage in 
a variety of settings. Therefore, we examined the effects 
on CNS structural integrity by examining both proteins 
in blood in response to an acute bout of soccer heading.
MATerIAls And MeThOds
study population and blood sample processing
This prospective controlled cohort study enrolled 11 
male soccer players, mean (SD) age 23.7 (3.9) years, with 
at least 5 years of experience playing at a highly compet-
itive level, and included three separate test conditions, 
completed in a pseudorandom order across partici-
pants, spaced at least 1 week apart. The three conditions 
were (1) heading, (2) sham and (3) control. For the 
heading condition, participants stood 25 m from a JUGS 
machine (JUGS International, Tualatin, Oregon, USA) 
and performed 40 approved headers in 20 min, with 30 
s separating each trial. The soccer used was a FIFA regu-
lation size 5 ball inflated to 13.0 psi and was propelled 
from the JUGS machine. Launch velocity for the study 
was determined by measuring launch velocity of corner 
kicks in a small pilot study through the use of an Adidas 
Smart Ball (Adidas America, Portland, Oregon, USA) 
and mimics the velocity from corner kicks in collegiate 
and professional soccer matches. The launch velocity for 
the heading condition was 77.4 (2.7) km/h (mean (SD)). 
Participants were asked to return at 22 days following the 
heading condition for a subsequent blood draw. The 
sham condition was identical to the heading condition 
except instead of using their head, participants made 
contact with the soccer balls directed at them with either 
the hands, chest or thigh. Launch velocity for the sham 
condition was 80.6 (3.1) km/h (mean (SD)). No soccer 
balls were launched during the control condition; partic-
ipants were taken to the testing area, waited 20 min and 
then returned to the laboratory for post-condition data 
collection.
blood sampling and quantification procedures
Blood samples were collected by standard venipuncture 
through a vein in the antecubital fossa into one K
2
EDTA 
tube for plasma and one tube for serum immediately 
before and 1 hour following each testing condition, and 
again at 3 weeks following the heading condition. Plasma 
samples were kept on ice until centrifugation, which 
occurred within 60 min of collection. Serum samples 
collected in the laboratory at the University of British 
Columbia were kept at room temperature for at least 30 
min to allow for coagulation.
Quantification of plasma tau and serum NF-L occurred 
on the single molecule array (Simoa) HD-1 analyser 
(Quanterix, Lexington, Massachusetts, USA), as previ-
ously described.22 The Simoa HD-1 analyser platform 
isolates individual capture beads in arrays of femtoli-
tre-sized reaction wells, resulting in assay sensitivity 1000 
times greater than conventional ELISA techniques.23 24 
Lower limit of quantification values were 1.22 pg/mL 
and 0.58 pg/mL for tau and NF-L, respectively, using 
standard, on-board 4-fold sample dilutions. Samples were 
run in duplicate over two separate runs on the same lot 
of reagents with samples from the same athlete run on 
the same plate by board-certified technicians blinded to 
the experimental conditions. The coefficient of variation 
values for high-quality and low-quality control samples 
run in conjunction with study samples were <12.6%.
symptom assessment
The Standardized Assessment of Concussion—3rd 
edition (SCAT3) was used to record the total number 
of symptoms and symptom severity scores before and 
after all conditions. The SCAT3 includes 22 symptoms 
of somatic, cognitive and neurobehavioural nature; each 
symptom is ranked on a Likert scale from 0 (no symptom) 
to 6 (severe). Total number of symptoms was determined 
by the total number of symptoms reported between 1 
and 6 (range 0–22). Symptom severity score is assessed 
by adding the severity for each symptom (range 0–132).
statistical analysis methods
Statistical analyses were conducted with SPSS V.23 (IBM) 
and figures were developed using GraphPad Prism 
V.7.0 (GraphPad Software, San Diego, California, USA). 
Separate paired tests were used to compare protein 
concentrations and SCAT3 metrics before and after each 
testing condition. Separate t-tests were used for compar-
isons between time points for normally distributed data, 
and the non-parametric Wilcoxon signed-rank test was 
used for comparisons of data that were not normally 
distributed. A value of p <0.05 was considered significant.
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Table 1 Biochemical variables and SCAT3 symptom metrics across all three experimental conditions
Variable
Heading
P values
Control
P values
Sham P 
valuesPre Post Pre Post Pre Post
NF-L, pg/mL 14.5 (17.8) 16.1 (17.7) 0.004* 26.9 (41.9) 28.5 (44.4) 0.19† 10.2 (22.7) 10.7 (23.2) 0.02†
Tau, pg/mL 3.2 (1.7) 3.0 (1.3) 0.16† 4.0 (5.2) 2.5 (3.3) 0.14† 3.5 (4.0) 3.8 (2.6) 0.58†
Total no of symptoms 1.6 (1.9) 7.0 (6.9) 0.01* 1 (5) 0 (3) 0.04† 2.3 (2.2) 0.9 (1.7) 0.04*
Symptom severity 0 (4) 6 (14) 0.03* 1 (7) 0 (3) 0.04† 2 (6) 0 (2) 0.04†
*t-test; associated data are mean (SD).
†Wilcoxon signed-rank test; associated data are median (IQR).
 NF-L, neurofilament light; SCAT3, Standardized Assessment of Concussion—3rd edition.
Figure 1 Percent change in serum neurofilament light (NF-L) protein following experimental conditions. Serum NF-L was 
significantly elevated following the heading (p=0.004) and sham (p=0.02) conditions compared with pre-condition values. No 
change was seen in serum NF-L following the control condition (p>0.05).
resulTs
Of the 11 total participants, all 11 completed the heading 
condition, 9 completed the sham condition and 9 
completed the control condition. Of the 11 participants 
who completed the heading condition, 7 returned at 22 
days (13–70) (median (range)) following the heading 
condition to provide an additional blood sample. Neuro-
filament light was quantifiable in all participants prior to 
and immediately following the heading condition and in 
8 of 9 participants that completed the sham and control 
conditions; tau was quantifiable in 9 of the 11 partic-
ipants prior to and immediately following the heading 
condition, 5 of the 9 participants who completed the 
sham condition, 8 of 9 who completed the control condi-
tion and 6 of 7 at the extended time point following the 
heading condition. SCAT3 metrics were recorded prior 
to and immediately after all conditions in all participants. 
All data are presented in table 1.
heading condition
Neurofilament light levels were significantly higher at 
1 hour following the heading condition (figure 1A), 
rising an average of 26%, t(10)=3.665, p=0.004. In addi-
tion, SCAT3 symptom metrics, including total number 
of symptoms, t(10)=2.979, p=0.01, and symptom severity 
score, t(10)=2.349, p=0.03, were significantly higher at 
1 hour following the heading condition compared with 
pre-heading levels. Spearman’s correlation coefficients 
for the relation between neurofilament light levels and 
total number of symptoms and symptom severity were 
not significant. At 22 days following the heading condi-
tion, NF-L levels were, on average, elevated 311% above 
baseline values, significantly higher compared with 
pre-heading measures, t(6)=2.602, p=0.04 (figure 2). 
Tau levels remained unchanged at 1 hour, z=1.400, 
p=0.16, and 22 days, t(5)=1.548, p=0.18, following 
an acute bout of soccer heading compared with 
pre-heading values.
sham condition
Both NF-L (figure 1B) and tau levels remained unchanged 
following the sham condition. Interestingly, the total 
number of symptoms, z=2.060, p=0.04, and symptom 
severity score, z=2.060, p=0.04, reported on the SCAT3 
were lower following the sham condition compared with 
pre-condition values.
Control condition
At 1 hour following the control intervention, NF-L was 
significantly higher, z=2.383, p=0.02, compared with 
pre-intervention values (figure 1C); however, post-con-
dition values were only 4% higher than those measured 
pre-condition, on average. Tau levels were unchanged 
from pre-condition to post-condition. Similar to the 
control condition, both the total number of symptoms, 
t(8)=2.490, p=0.04, and symptom severity scores, z=2.023, 
p=0.04, were lower following the control condition 
compared with pre-intervention values.
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Figure 2 Percent change in serum neurofilament light (NF-
L) 3 weeks following an acute bout of soccer heading. Serum 
NF-L remained elevated 3 weeks following the heading 
condition (p=0.04).
dIsCussIOn
The ability to accurately head the ball in soccer is a key 
component to the game. We believe this is the first study 
to measure serum NF-L, plasma tau and SCAT3 metrics 
immediately prior to and again at 1 hour and 22 days 
following an acute bout of soccer heading involving 40 
headers performed at speeds mimicking those seen in 
professional play. Interestingly, NF-L was increased at 1 
hour and 22 days following the heading condition, while 
tau remained unchanged. Further, an increase in NF-L 
was seen at 1 hour following the control condition. The 
total number of symptoms reported and the associated 
symptom severity scores both increased following an 
acute bout of soccer heading; however, following both the 
sham and control conditions, the two metrics decreased. 
As serum NF-L is considered a biomarker of axonal injury 
in the brain,25 this study suggests that repetitive, subcon-
cussive impacts in the form of soccer headers can cause 
axonal damage and increase the number and severity of 
symptoms commonly reported post-concussion.
Although we report increased concentrations of NF-L 
at 1 hour and 22 days following an acute bout of soccer 
heading, tau remained unchanged. This could be due to 
the fact that increased plasma tau seems to be associated 
with more severe impacts. Higher levels of plasma tau are 
seen in those experiencing a longer return-to-play due to 
the presence of post-concussion symptoms and in indi-
viduals experiencing a loss of consciousness following 
SRC.16 26 NF-L levels were higher 1 hour and 22 days 
following the heading condition; this may indicate that 
NF-L is more sensitive to low-level impacts. Indeed, NF-L 
has been shown to increase over the course of an Amer-
ican football season,21 indicating that serum NF-L may 
be useful in detecting axonal trauma following repetitive 
subconcussive impacts.
The SCAT3 is a standardised clinical tool used to 
assess an athlete’s condition following a suspected 
SRC. Following the heading condition, both the total 
number of symptoms and symptom severity scores were 
increased compared with pre-heading values, indicating 
that repetitive headers in soccer travelling at 80 km/h 
can bring about symptoms commonly seen in those with 
post-concussion syndrome. This contrasts previous study 
findings,27 although the number of headers performed 
(ie, 5) was much lower than the current study (ie, 40). 
Intriguingly, both the total number of symptoms and 
symptom severity scores decreased following the sham 
and control conditions compared with pre-condition 
values. With respect to the sham condition, in which 
athletes guided the ball down using their chest, hands 
or legs, the decrease could be due to the participa-
tion, although brief, in physical activity required of the 
condition. Collegiate athletes have reported improved 
self-esteem and lower levels of depression compared with 
non-athletes,28 and so this may explain the decrease in 
SCAT3 symptom metrics.
This study is not without limitations. As this was part 
of a larger study, the sample size is small. This was a 
protracted study with three separate testing conditions 
lasting approximately 2.5–3 hours per condition. As such, 
some participants did not complete all five conditions. 
Although the players were not in season during the dura-
tion of the study, no restrictions could be enforced to 
limit exposure to head impacts in pick up soccer games 
or practice conditions. Symptom metrics on the SCAT3 
were not recorded at the 22 days time point following 
the heading condition; however, as we could not limit 
the exposure to head impacts, and the list of symptoms 
included on the SCAT3 are not specific to those who 
experience head trauma, we believe there were too many 
confounding variables to accurately deduce an associa-
tion with SCAT3 symptom metrics and an acute bout of 
soccer heading 22 days prior.
In conclusion, this study suggests that exposure to 
repetitive, subconcussive yet high-velocity head impacts 
in the form of soccer headers may result in axonal 
damage that can be detected using ultrasensitive immu-
noassay methods. Players can head the ball up to 12 
times per game,2 29 and with approximately 40 games 
played in a professional season a player may potentially 
head the ball between 400 and 500 times per season, not 
including those performed in practice. The results from 
the current study suggest that heading in soccer should 
not be overlooked as a potential mechanism for axonal 
damage. Indeed, more research is needed in order to 
help elucidate the possibility of such a relationship.
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